Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Modern Rheumatology|May 22, 2010
Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosusKazuhiro Kurasawa, Satoko Arai, Takayoshi Owada, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|July 15, 2021
Long-term outcome of Wilson's disease complicated by liver diseaseSatoko Arai, Tomomi Kogiso, Yuri Ogasawara, et al.
Experimental Eye Research|November 12, 2003
Protective role of heme oxygenase-1 against endotoxin-induced uveitis in ratsKouichi Ohta, Takanobu Kikuchi, Satoko Arai, et al.
Experimental Animals|November 30, 2018
AIM-deficient mouse fed a high-trans fat, high-cholesterol diet: a new animal model for nonalcoholic fatty liver diseaseGinga Komatsu, Toru Nonomura, Mai Sasaki, et al.
Modern Rheumatology|April 3, 2012
Positivity for anti-RNP antibody is a risk factor for adverse effects caused by trimethoprim-sulfamethoxazole, a prophylactic agent for P. jiroveci pneumonia, in patients with connective tissue diseasesReika Maezawa, Kazuhiro Kurasawa, Satoko Arai, et al.
International Immunology|February 10, 2017
Inflammatory and anti-inflammatory states of adipose tissue in transgenic mice bearing a single TCRAyaka Matsumoto, Kaori Taniguchi, Naoki Takeda, et al.
Investigative Ophthalmology & Visual Science|October 27, 2004
Heme oxygenase-1 induced in muller cells plays a protective role in retinal ischemia-reperfusion injury in ratsSatoko Arai-Gaun, Naomichi Katai, Takanobu Kikuchi, et al.
Plos One|November 29, 2021
High salt exacerbates acute kidney injury by disturbing the activation of CD5L/apoptosis inhibitor of macrophage (AIM) proteinChing-Ting Wang, Tetsushi Tezuka, Naoki Takeda, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 7, 2011
Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissueJun Kurokawa, Hiromichi Nagano, Osamu Ohara, et al.
Modern Rheumatology|September 29, 2009
Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosusKuniyoshi Kamiya, Kazuhiro Kurasawa, Satoko Arai, et al.
Pageof 10